Form4insider filings, from the source

SEC Form 4 · accession 0002109966-26-000006

NovaBridge Biosciences · NBP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Sean Wuxiong Cao
Officer — Chief Bus. Development Officer
Period of report
Sep 3, 2026
Accepted (ET)
Sep 8, 2026 · 5:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001778016

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2,F3Sep 3, 2026M235,136—A270,209D
Ordinary SharesF1,F4,F3Sep 3, 2026M104,236—A374,445D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share UnitsF3,F5,F1—Sep 3, 2026M102,233D——Ordinary Shares102,233306,700D
Restricted Share UnitsF3,F6,F1—Sep 3, 2026M45,320D——Ordinary Shares45,320135,960D

Explanation of responses